Company PharmaRoth Labs, Inc. Other OTC

ROTH

US71715Y1029

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Pharmaceuticals

Inactive Instrument

PharmaRoth Labs, Inc. is a nutraceutical company that is focused on the prevention and treatment of healthcare diabetes. The Company is engaged in the production, marketing, and distribution of Sucanon, a clinically-tested herbal-based nutraceutical treatment for type II diabetes. Sucanon is a medication that helps the body make better use of its own insulin, the hormone that controls blood sugar levels.

USD in Million	2016	Weight	2017	Weight	Delta
Nutraceutical Drugs 100.0 %	0	100.0 %	0	100.0 %	-31.08%

USD in Million	2016	Weight	2017	Weight	Delta
Americas 100.0 %	0	100.0 %	0	100.0 %	-31.08%

Managers	Title	Age	Since
Luis Manuel Ornelas Lopez CEO	Chief Executive Officer	-	31/10/31
Barry W. Hall DFI	Director of Finance/CFO	76	22/13/22

Members of the board	Title	Age	Since
Luis Manuel Ornelas Lopez CEO	Chief Executive Officer	-	31/10/31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	394,014,970	121,850,000 ( 30.93 %)	0	30.93 %

PharmaRoth Labs, Inc.

10080 West Alta Drive Suite 115

89145, Las Vegas

+212-541-6222

http://www.pharmaroth.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+34.35%	71TCr
NOVO NORDISK A/S	+29.39%	58TCr
JOHNSON & JOHNSON	-3.49%	36TCr
MERCK & CO., INC.	+20.15%	33TCr
ABBVIE INC.	+6.19%	29TCr
ASTRAZENECA PLC	+14.11%	24TCr
ROCHE HOLDING AG	-3.03%	21TCr
NOVARTIS AG	+10.02%	21TCr
AMGEN INC.	+9.21%	17TCr

Other Pharmaceuticals